Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
株式のランク #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
株価
$0.00001
最終同期: 2025-12-30
時価総額
$6.89K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 AVAX Technologies, Inc. (AVXT)

カテゴリー

AVAX Technologies, Inc.(AVXT)の配当利回りの履歴
AVAX Technologies, Inc.(銘柄コード: AVXT)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
AVAX Technologies, Inc.(AVXT)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)